IR Licensing and Partnerships

Latest News

February 13th 2025

Novartis Strikes Deal to Acquire Anthos Therapeutics

Acquisition includes abelacimab, a Factor XI-inhibiting monoclonal antibody in development for stroke prevention in patients with atrial fibrillation and cancer-associated thrombosis.

February 12th 2025

Abcuro Secures $200 Million in Series C Funding to Advance Ulviprubart for Inclusion Body Myositis

By Don Tracy, Associate Editor

January 30th 2025

ImmunityBio, BeiGene Strike Deal to Conduct Phase III Trial for Tislelizumab, Anktiva in Advanced or Metastatic Non-Small Cell Lung Cancer

By Don Tracy, Associate Editor

IR Licensing and Partnerships

Latest News

Trending on PharmExec

How is Boehringer Ingelheim's Deliberate GLP-1 Strategy Different From Competitors?

Evolving Beyond Launch Postmortems to Real-Time Optimization

Expanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylor

FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report

Biogen Enters $1 Billion Agreement to Acquire RayThera Inc.